Drug Shortage Report for ADLYXINE

Last updated on 2022-12-05 History
Report ID 173834
Drug Identification Number 02464284
Brand name ADLYXINE
Common or Proper name ADLYXINE 20
Company Name SANOFI-AVENTIS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) LIXISENATIDE
Strength(s) 20MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size Pack of 2 pre-filled pens
ATC code A10BJ
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2022-11-01
Estimated end date 2022-12-02
Actual end date 2022-11-17
Shortage status Resolved
Updated date 2022-12-05
Company comments Requirements related to complying with good manufacturing practices.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-12-05 French Compare
v6 2022-12-05 French Compare
v5 2022-12-05 English Compare
v4 2022-11-17 French Compare
v3 2022-11-17 English Compare
v2 2022-11-04 French Compare
v1 2022-11-04 English Compare

Showing 1 to 7 of 7